Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
02/2008
02/20/2008EP1889639A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents
02/20/2008EP1889624A2 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites
02/20/2008EP1889617A1 Triphenyl modified 5-membered heterocycles and their use as anticancer and antiflammatory agents
02/20/2008EP1888564A2 Benzofuran compounds
02/20/2008EP1888562A2 Dipeptidyl peptidase-iv inhibitors
02/20/2008EP1888524A1 Androgen modulators
02/20/2008EP1888523A2 Cyclobutyl amine derivatives
02/20/2008EP1888518A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
02/20/2008EP1675832B1 Heterocyclyl compounds
02/20/2008CN101128446A Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine
02/20/2008CN101128423A Novel lipoxygenase inhibitors
02/20/2008CN101125829A Vinylbiphenyl compounds
02/20/2008CN101125828A Synthesis method for alpha-carbonylenamine derivative cooling agent (3-MPC) and application thereof
02/20/2008CN101125138A Inhibitors against the production and release of inflammatory cytokines
02/20/2008CN100369896C Cyclic amino compounds
02/20/2008CN100369891C HIF hydroxylase inhibitors
02/19/2008US7332631 Fc receptor modulating compounds and compositions
02/19/2008US7332608 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis
02/19/2008US7332524 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
02/19/2008US7332518 Carboxamides as fungicides in agriculture
02/19/2008US7332516 pathogenic form of amyloid beta polypeptides inhibitor; 2-(2-Fluoro-1,1'-biphenyl-4-yl)-2-methylpropanoic acid; nonsteroidal antiinflammatory agent, neuroprotectant, ; side effect reduction; cyclooxygenase inhibitor; Alzheimer's disease, cognition activator, neurogenerative disease
02/19/2008US7332512 Halogenated nitrobutadienes for controlling animal pests
02/19/2008US7332508 heterocyclic amines such as 1-Cyclopentyl-4-{2-[5-(4-methanesulfonylphenyl)[1,2,4]oxadiazol-3-yl]ethyl}piperidine and salts, used as histamine-H3 receptor antagonists for treatment of nervous system, cardiovascular , respiratory system, gastrointestinal system and endocrinological system disorders
02/19/2008US7332487 Nitrogen-containing 5-membered ring compound
02/19/2008US7332483 3-(5-benzamido-2-chlorophenyl)-7-methoxy-3,4-dihydroquinazolin-4-one;cytokines (tumor necrosis factor and interleukins) inhibitor; antiinflammatory agent, rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease
02/19/2008CA2328927C Benzamide derivatives for the treatment of diseases mediated by cytokines
02/19/2008CA2206366C Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
02/14/2008WO2008019302A1 Pyrazolylphenyl and pyrrolylphenyl inhibitors of lta4h for treating inflammation
02/14/2008WO2008019284A1 Phenoxymethylalkyne inhibitors of lta4h for treating inflammation
02/14/2008WO2008018544A1 Sulfonamide compound or salt thereof
02/14/2008US20080039634 Novel onium salt, electrolyte for nonaqueous cell containing the novel onium salt for nonaqueous cell and method for optimizing negative electrode using electrolyte containing onium salt
02/14/2008US20080039518 Maleiimide anti-tumor phosphatase inhibitors
02/14/2008US20080039517 2-chloro-4-{[(3S)-1-methyl-5-oxo-3-pyrrolidinyl][(2-methylphenyl)methyl]amino}benzonitrile; for treatment of endometreosis, uterine fibroids, dysmenorrhea, menorrhagia, pre-term labor, or infertility
02/14/2008US20080039505 5-((((2R)-1-(4-((S)-1-hydroxyhexyl)phenyl)-4-methyl-5-oxopyrrolidin-2-yl)methoxy)methyl)thiophene-2-carboxylic acid; glaucoma or ocular hypertension
02/14/2008US20080039470 Acylaminoheteroaryl hepatitis C virus protease inhibitors
02/14/2008US20080038276 carbamimidoyl benzylamide derivatives; preventing and treating the formation of thrombin during or after a PK dependent disease or condition after fibrinolysis treatment
02/14/2008CA2660424A1 Sulfonamide compound or salt thereof
02/13/2008EP1463716B1 Pyrrolidine and piperidine derivates as nk1 antagonists
02/13/2008EP1404650B1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
02/13/2008CN101124201A Parp抑制剂 Parp inhibitors
02/13/2008CN101124199A 5-substituted-2-phenylamino-benzamide as MEK inhibitor
02/13/2008CN101121688A Improved method for synthesizing oxiracetam
02/13/2008CN101121687A N-substituted benzyl-alpha,alpha-disubstituted phenyl-2-pyrrolidinemethanol derivatives, preparation method and agricultural composition thereof
02/13/2008CN100368397C Prodrugs to d-prolines
02/13/2008CN100368394C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
02/13/2008CN100368392C Bifunctional phenyliso(thio)cyanates, processes and intermediates products for their preparation
02/13/2008CN100367949C Melanin extinguisher
02/12/2008US7329767 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
02/12/2008US7329765 Benzothiophene compounds having antiinfective activity
02/12/2008US7329763 Creatine pyroglutamic acid salts and methods for their production and use in individuals
02/12/2008US7329762 Prodrugs of mitotic kinesin inhibitors
02/12/2008US7329755 especially naphthalene sulfonamides, used for treating asthma
02/12/2008US7329685 1-Phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor Xa inhibitors for the treatment of acute vascular diseases
02/12/2008US7329634 pesticides and herbicides; dehalogenation and reduction of 3-[(2-ethyl-4-bromo-6-methyl)phenyl]-5,5-pentamethylenepyrrolidine-2,4-dione with halogenating agent in presence of solvent and free radical initiator; animal pests and crops controlling
02/12/2008US7328745 Acid ammonium salts of an imide of polymaleic anhydride; hydraulic fracturing fluids used in enhanced oil recovery
02/12/2008CA2496623C Benzenesulfonate salts of 4-fluoro-2-cyanopyrrolidine derivatives
02/12/2008CA2258701C Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
02/07/2008WO2008016007A1 METALLO-β-LACTAMASE INHIBITOR
02/07/2008WO2008014821A1 3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective cox-2 inhibitors
02/07/2008WO2007146719A3 2-aminocarbonylphenylamino-2-phenylacetamides as factor viia inhibitors useful as anticoagulants
02/07/2008WO2007035722B1 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
02/07/2008WO2006105304A8 Phenyl and pyridyl lta4h modulators
02/07/2008US20080033033 8-azaprostaglandin derivatives and medical use thereof
02/07/2008US20080033032 Novel Polymorphs Of The Potassium Salt Of Atorvastatin
02/07/2008US20080033023 Therapeutic compounds
02/07/2008US20080033013 Pyrazolylphenyl and pyrrolylphenyl inhibitors of lta4h for treating inflammation
02/07/2008US20080033012 Enzyme inhibitors
02/07/2008US20080032981 Aryl n-cyanoguanidines and methods related thereto
02/07/2008US20080032979 Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors
02/07/2008US20080031951 Compositions and methods for the inhibition of phospholipase A2
02/07/2008CA2659693A1 3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective cox-2 inhibitors
02/06/2008EP1883627A1 Bir domain binding compounds
02/06/2008EP1883402A2 Hydroxybenzamide derivatives and their use as inhibitors of hsp90
02/06/2008CN101119967A Derives de 1,5-diarylpyrrole, leur preparation et leur application en therapeutique
02/06/2008CN101119965A Tetralin and indane derivatives and uses thereof
02/06/2008CN101119963A Methamphetamine derivatives and conjugates for immunoassay
02/06/2008CN101117328A Fatty acid synthetase inhibitor and application for treating bacterial infection
02/06/2008CN100366608C New process for preparing 4-aminomethyl-3-alkoxyiminopyrrolidine methanesulfonate
02/06/2008CN100366605C Compounds to treat alzheimer's disease
02/05/2008US7326812 Arylsulfonamidobenzylic compounds
02/05/2008US7326799 Oxidizing an amino alcohol (obtained by ring opening the epoxy, aziding, reducing and reacting it with a carboxylic acid); stereoselectivity; protease inhibitors: antiallergens; anticarcinogenic and hypotensive agents
02/05/2008US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance
02/05/2008US7326785 Preparation of 3-(thienylalkenylenesulfonylamino)-1-(4--morpholinylcarbonyl-alpha-substituted methyl)pyrrolidone derivatives: 2-(5-Chlorothien-2-yl)-N-methyl-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide
02/05/2008US7326731 Muscarinic agonists
02/05/2008US7326729 CXCR1 and CXCR2 chemokine antagonists
02/05/2008US7326707 Bicyclic melanocortin-specific compounds
02/05/2008US7326696 Amino-methyl substituted tetracycline compounds
02/05/2008CA2449445C Fluorous triphase and other multiphase systems
02/05/2008CA2284977C 3,3-disubstituted propylamines, their use and preparation
01/2008
01/31/2008WO2008014381A2 Modulators of chemokine receptor activity, crystalline forms and process
01/31/2008WO2008014360A2 Modulators of chemokine receptor activity, crystalline forms and process
01/31/2008WO2008014311A2 Inhibitors of undecaprenyl pyrophosphate synthase
01/31/2008WO2008013130A1 Method for production of optically active 3-amino-nitrogenated compound
01/31/2008WO2008012524A1 Substituted aniline derivatives
01/31/2008WO2008012268A1 Process for the preparation of levetiracetam
01/31/2008WO2008012231A2 Use of 1,5-dimethylpyrrolidone
01/31/2008US20080027262 Method for Producing Alkenses by the Elimination of Water from Alcohols, Using Alkylphosphonic Acid Anhydrides
01/31/2008US20080027232 Reacting a dialkylboron-X where X is a leaving group with a 1-acyldipyrromethane; complex formed may be combined with a hindered alkyl amine base, such as triethylamine, diisopropylethylamine, or triphenylamine, in an organic solvent to form a solid; product may be decomplexed by contact with an OH
01/31/2008US20080027228 Substituted thioacetamides
01/31/2008US20080027222 Chemiluminescent reagents